image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Synergy Health - Brewin lifts price target

August 2011

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SYR
  • Price:
  • 935p
Since our last update the shares have soared through the £9 barrier and now stand a massive 314% ahead of the 226p at which we added them to the Trader Portfolio back in July 2003. The catalyst for the latest uptick were impressive final results, in which turnover was virtually unchanged at £287.3m, but largely thanks to a 1.1% rise in operating margin to 15%, saw pretax profit rise 17.3% to £38.3m. Eps increased 17.1% to 53.5p, while the dividend was raised a notable 20% to 15.8p. Meanwhile net debt fell by £21.1m to £112.3m while the forward order book rose 8% to £920m.Synergy's core activity of medical device sterilisation services delivered 14% sales growth of which 10% was organic, helped by a change of ownership ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe